HIF1A and pulmonary arterial hypertension: In SMCs, HIF-1α is decreased in PAH patients and myosin light chain phosphorylation (pMLC), a central determinant of vascular tone, is increased in patients with PAH, suggesting that in these cells HIF-1α works inversely to promote pulmonary vascular contractility [78].